mRNA, the beginning of a new influenza vaccine game
- PMID: 36469761
- PMCID: PMC9897424
- DOI: 10.1073/pnas.2217533119
mRNA, the beginning of a new influenza vaccine game
Conflict of interest statement
S.P. is a full time employee and stockholder of the GSK group of companies. R.R. is stockholder of Novartis and the GSK group of companies.
Figures
Comment on
-
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2206333119. doi: 10.1073/pnas.2206333119. Epub 2022 Nov 2. Proc Natl Acad Sci U S A. 2022. PMID: 36322769 Free PMC article.
References
-
- World Health Organization (WHO), Influenza (seasonal). https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 16 October 2022.
-
- Palese P., Influenza: Old and new threats. Nat. Med. 10, S82–S87 (2004). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical